
Cancer Biology 2019 greetings you to attend the "3rd World Congress on Cancer Biology and Immunology" under the theme of "Don't count the days make the Days Count" during March 11-12, 2019 at Milan, Italy. Cancer Biology 2019 is the premier event that unites an interesting and International blend of specialists, analysts and leaders both from the academia world and industry over the globe to trade their insight, experience and research advancements to build Cancer Research researchers, industrialists and business visionaries meet.
Cancer is caused when cells inside the body accumulate genetic changes and begin to develop in an uncontrolled way. Cancer biology is understanding how cancer creates and advances, including how gene mutations drive the development and spread of cancer cells, and how tumors communicate with their encompassing condition, is crucial for the discovery of new focused on malignancy treatment.Immunology is the study of the immune system and is an important branch of the restorative and organic sciences. The immune system protects us from disease through different lines of barrier. If the immune system isn't working as it should, it can bring about sickness, for example, autoimmunity, allergy and cancer.
Dean L. Mann
University of Maryland School of Medicine, USA
Hanan Polansky
The Center for the Biology of Chronic Disease, USA
Marilena Iorio
IRCCS Foundation - National Cancer Institute, Italy
Liqin Du
Texas State University
USA
Perea Garcia Jose
Fundacion Jimenez Diaz University Hospital, Spain
Hani Al-Afghani
Security Forces Hospital
Saudi Arabia
David Bates
University of Nottingham
United Kingdom
Ratna Parikh
Breach Candy Hospital
India
Claudio Luchini
Verona University
Italy
Quincy A. Quick
Tennessee State University
USA
Valerie E. Cadet
Philadelphia College of Osteopathic Medicine, USA
Toru Kondo
Hokkaido University
Japan
Ola H Negm
University of Nottingham
United Kingdom
Silvia Martina Ferrari
University of Pisa
Italy
Lian Yun Li
University of Chinese Medicine
China
Barry John Allen
Western Sydney University
Australia
Simona Romano
University of Naples Federico II
Italy
Neda Zarrin-Khameh
Baylor College of Medicine
USA
Ichiro Maruyama
Okinawa Institute of Science and Technology, Japan
Varda Shoshan-Barmatz
Ben-Gurion University
Isreal
Uri Wormser
Hebrew University of Jerusalem
Isreal
Viktor Brabec
Czech Academy of Sciences
Czech Republic
Jana Kasparkova
Czech Academy of Sciences
Czech Republic
Giorgia Simonetti
I.R.S.T
Italy
Alessia Cordaro
Bracco Imaging SpA
Italy
Emma M. Creagh
Trinity College Dublin
Ireland
Roland Sennerstam
Karolinska Institute
Sweden
Cancer is the second driving reason for death around the world. It's urgent to recall that tumor isn't one disease – it's in excess of 250 malignancy infections included. All extraordinary, remarkable diseases, which require diverse methodologies for treatment. Medicines that work for a few growths don't work for others and here and there those medications just quit working. Just overall research will improve our comprehension of growth and help us find and grow better, more successful medicines. What's more, just a worldwide look for answers will enable us to get to grasps with this sickness. The meeting will give an extraordinary open door for the agents from Universities and Institutes to connect with the world class Scientists and Industry Professionals working in the field of cancer biology. The meeting will furnish with an uncommon open door for the delegates also from Universities and Institutes to collaborate with the world class Scientists and Industry Professionals working in the field of disease/oncology.
Cancer Biology 2019 is the premier event that unites a one of a kind and worldwide specialists, analysts, researchers and leaders both from the academic and industry over the world to trade their insight, skill and research advancements in the field of cancer treatment. This zenith unites the senior level specialists with an ideal mix for multidisciplinary coordinated effort between innovators, researchers, academicians from everywhere throughout the world working in the distinctive field of Cancer, Oncology Research , Immunology and Immuno-oncology .
Mark Agulnik
Northwestern Memorial Hospital
USA
Kui Lin
Genentech
USA
Jane Grogan
Genentech
USA
Bhagavatula Moorthy
Baylor College of Medicine
USA
Andrei V. Bakin
Roswell Park Cancer Institute
USA
Bharat B. Mittal
Northwestern University
USA
Yan Dong
Tulane University
USA
Jianying Zhang
The University of Texas
USA
Diana Anderson
University of Bradford
UK
Jenkins
Monash University
Australia
Belamy Cheung
Lowy Cancer Research Centre
Australia
Smitha Georgy
Monash University
Australia
Justin Wong
Centenary Institute
Australia
Lei Jin
The University of Newcastle
Australia
Eva Dimitriadis
Hudson Institute of Medical Research, Australia
Nicholas Fletcher
University of Queensland
Australia
Max Nobis
University of New South Wales
Australia
Hang Thu Ta
University of Queensland
Australia
Aljawharah Alqathama
Umm Al-Qura University
Saudi Arabia
Noboru Nakaigawa
Yokohama City University Graduate School of Medicine, Japan
Neha Girish Sabnis
Core Diagnostics
India
Jens Christian Larsen(Retd.)
Denmark
Eliphaz Mukasa
University of Witwatersrand
South Africa
Qingjuan Chen
Xian Yang Central Hospital
China
Xi Chen
Zhejiang University
China
Wei-Dong Chen
Henan University
China
Yan-Dong Wang
Beijing University of Chemical Technology, China
Xue-qian Qian
Zhejiang University
China
William Jia
Virogin Biotech Ltd
Canada
Iris Lavon
Hadassah Hebrew University Medical Center, Israel
Yeu Su
National Yang-Ming University
Taiwan
Chia-Hwa Lee
Taipei Medical University
Taiwan
Kazushige Yokoyama
Kaohsiung Medical University
Taiwan